Higher levels of some TLR4 downstream cytokines (e.g., IL-8) have been observed in prostate cancer tissues compared with control non-tumor tissues (59), suggesting that prostate cells experience persistent elevated inflammation presumably in response to bacterial products such as LPS as well as endogenous TLR4 ligands released from injured cells. Here, CXCL8 is linked to prostate carcinoma.